• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发针对包膜糖蛋白受体结合部位的肽来遏制西尼罗河病毒感染。

Development of peptides targeting receptor binding site of the envelope glycoprotein to contain the West Nile virus infection.

机构信息

Laboratory of Biomedical Microbiology and Immunology, The University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 04181, Košice, Slovakia.

Institute of Neuroimmunology of Slovak Academy of Sciences, Dubravska cesta 9, 84510, Bratislava, Slovakia.

出版信息

Sci Rep. 2021 Oct 11;11(1):20131. doi: 10.1038/s41598-021-99696-w.

DOI:10.1038/s41598-021-99696-w
PMID:34635758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8505397/
Abstract

West Nile virus (WNV), re-emerging neurotropic flavivirus, can cross the blood-brain barrier (BBB) and cause fatal encephalitis and meningitis. Infection of the human brain microvascular endothelial cells (hBMECs), building blocks of the BBB, represents the pivotal step in neuroinvasion. Domain III (DIII) of the envelope (E) glycoprotein is a key receptor-binding domain, thus, it is an attractive target for anti-flavivirus strategies. Here, two combinatorial phage display peptide libraries, Ph.D.-C7C and Ph.D.-12, were panned against receptor-binding site (RBS) on DIII to isolate peptides that could block DIII. From series of pannings, nine peptides (seven 7-mer cyclic and two 12-mer linear) were selected and overexpressed in E. coli SHuffle T5. Presence of disulfide bond in 7-mer peptides was confirmed with thiol-reactive maleimide labeling. Except for linear peptide 19 (HYSWSWIAYSPG), all peptides proved to be DIII binders. Among all peptides, 4 cyclic peptides (CTKTDVHFC, CIHSSTRAC, CTYENHRTC, and CLAQSHPLC) showed significant blocking of the interaction between DIII and hBMECs, and ability to neutralize infection in cultured cells. None of these peptides showed toxic or hemolytic activity. Peptides identified in this study may serve as potential candidates for the development of novel antiviral therapeutics against WNV.

摘要

西尼罗河病毒(WNV)是一种重新出现的神经嗜性黄病毒,能够穿透血脑屏障(BBB),导致致命性脑炎和脑膜炎。感染人类脑微血管内皮细胞(hBMECs)是神经入侵的关键步骤,hBMECs 是 BBB 的组成部分。包膜(E)糖蛋白的结构域 III(DIII)是关键的受体结合域,因此,它是抗黄病毒策略的有吸引力的靶标。在这里,两个组合噬菌体展示肽文库 Ph.D.-C7C 和 Ph.D.-12 针对 DIII 上的受体结合位点(RBS)进行了淘选,以分离能够阻断 DIII 的肽。经过一系列淘选,从 7 个 7 -mer 环肽和 2 个 12-mer 线性肽中选择了 9 个肽,并在 E. coli SHuffle T5 中过表达。用硫醇反应性马来酰亚胺标记证实了 7-mer 肽中存在二硫键。除了线性肽 19(HYSWSWIAYSPG)外,所有肽都被证明是 DIII 结合物。在所有肽中,4 个环肽(CTKTDVHFC、CIHSSTRAC、CTYENHRTC 和 CLAQSHPLC)显示出对 DIII 与 hBMECs 之间相互作用的显著阻断作用,并具有中和培养细胞中感染的能力。这些肽没有表现出毒性或溶血活性。本研究中鉴定的肽可能成为开发针对 WNV 的新型抗病毒治疗药物的潜在候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47e/8505397/957507888dd8/41598_2021_99696_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47e/8505397/424c246b37d3/41598_2021_99696_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47e/8505397/91822b4e51a3/41598_2021_99696_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47e/8505397/56b6bdc541cc/41598_2021_99696_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47e/8505397/5bc1f180d336/41598_2021_99696_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47e/8505397/94820edf9c46/41598_2021_99696_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47e/8505397/957507888dd8/41598_2021_99696_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47e/8505397/424c246b37d3/41598_2021_99696_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47e/8505397/91822b4e51a3/41598_2021_99696_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47e/8505397/56b6bdc541cc/41598_2021_99696_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47e/8505397/5bc1f180d336/41598_2021_99696_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47e/8505397/94820edf9c46/41598_2021_99696_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47e/8505397/957507888dd8/41598_2021_99696_Fig6_HTML.jpg

相似文献

1
Development of peptides targeting receptor binding site of the envelope glycoprotein to contain the West Nile virus infection.开发针对包膜糖蛋白受体结合部位的肽来遏制西尼罗河病毒感染。
Sci Rep. 2021 Oct 11;11(1):20131. doi: 10.1038/s41598-021-99696-w.
2
Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection.西尼罗河病毒重组包膜结构域III蛋白免疫可诱导特异性免疫反应并提供针对西尼罗河病毒感染的保护。
J Immunol. 2007 Mar 1;178(5):2699-705. doi: 10.4049/jimmunol.178.5.2699.
3
Antiviral peptides targeting the west nile virus envelope protein.靶向西尼罗河病毒包膜蛋白的抗病毒肽。
J Virol. 2007 Feb;81(4):2047-55. doi: 10.1128/JVI.01840-06. Epub 2006 Dec 6.
4
Engineering the Single Domain Antibodies Targeting Receptor Binding Motifs Within the Domain III of West Nile Virus Envelope Glycoprotein.工程化靶向西尼罗河病毒包膜糖蛋白结构域III内受体结合基序的单域抗体
Front Microbiol. 2022 Apr 1;13:801466. doi: 10.3389/fmicb.2022.801466. eCollection 2022.
5
A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.植物源疫苗可预防小鼠感染致死性西尼罗河病毒,而不增强寨卡病毒或登革热病毒的感染力。
Vaccine. 2018 Mar 27;36(14):1846-1852. doi: 10.1016/j.vaccine.2018.02.073. Epub 2018 Feb 26.
6
West Nile virus-induced cell adhesion molecules on human brain microvascular endothelial cells regulate leukocyte adhesion and modulate permeability of the in vitro blood-brain barrier model.西尼罗河病毒诱导人脑血管内皮细胞上的细胞黏附分子调节白细胞黏附并调节体外血脑屏障模型的通透性。
PLoS One. 2014 Jul 18;9(7):e102598. doi: 10.1371/journal.pone.0102598. eCollection 2014.
7
A recombinant fusion protein consisting of West Nile virus envelope domain III fused in-frame with equine CD40 ligand induces antiviral immune responses in horses.一种由西尼罗河病毒包膜结构域III与马CD40配体读码框融合而成的重组融合蛋白可在马体内诱导抗病毒免疫反应。
Vet Microbiol. 2017 Jan;198:51-58. doi: 10.1016/j.vetmic.2016.12.008. Epub 2016 Dec 8.
8
A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.一种基于病毒样颗粒的西尼罗河病毒 E 蛋白结构域 III 疫苗可保护小鼠免受致死性感染。
Virol J. 2010 Jul 6;7:146. doi: 10.1186/1743-422X-7-146.
9
Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step.自然感染诱导产生的抗西尼罗河病毒人单克隆抗体在病毒附着后步骤发挥中和作用。
J Virol. 2009 Jul;83(13):6494-507. doi: 10.1128/JVI.00286-09. Epub 2009 Apr 22.
10
Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.利用包膜糖蛋白的重组结构域III抑制西尼罗河病毒进入。
J Gen Virol. 2005 Feb;86(Pt 2):405-412. doi: 10.1099/vir.0.80411-0.

引用本文的文献

1
West Nile virus - a re-emerging global threat: recent advances in vaccines and drug discovery.西尼罗河病毒——一种再度出现的全球威胁:疫苗与药物研发的最新进展
Front Cell Infect Microbiol. 2025 May 15;15:1568031. doi: 10.3389/fcimb.2025.1568031. eCollection 2025.
2
Peptides developed against receptor binding sites of the E glycoprotein neutralize tick-borne encephalitis virus.针对E糖蛋白受体结合位点开发的肽可中和蜱传脑炎病毒。
Sci Rep. 2025 Apr 3;15(1):11435. doi: 10.1038/s41598-025-95449-1.
3
Antimicrobial cyclic peptides effectively inhibit multiple forms of Borrelia and cross the blood-brain barrier model.

本文引用的文献

1
Developing cyclic peptide-based drug candidates: an overview.开发基于环肽的候选药物:综述。
Future Med Chem. 2020 Oct;12(19):1687-1690. doi: 10.4155/fmc-2020-0171. Epub 2020 Sep 25.
2
A simple and rapid pipeline for identification of receptor-binding sites on the surface proteins of pathogens.一种用于鉴定病原体表面蛋白上受体结合位点的简单、快速的方法。
Sci Rep. 2020 Jan 24;10(1):1163. doi: 10.1038/s41598-020-58305-y.
3
Antiviral activity of phage display-selected peptides against Japanese encephalitis virus infection in vitro and in vivo.
抗菌环肽可有效抑制多种形式的疏螺旋体,并能穿过血脑屏障模型。
Sci Rep. 2025 Feb 20;15(1):6147. doi: 10.1038/s41598-025-90605-z.
4
An Overview of Antiviral Peptides and Rational Biodesign Considerations.抗病毒肽概述及合理的生物设计考量
Biodes Res. 2022 May 17;2022:9898241. doi: 10.34133/2022/9898241. eCollection 2022.
5
The Anti-Dengue Virus Peptide DV2 Inhibits Zika Virus Both In Vitro and In Vivo.抗登革热病毒肽 DV2 在体外和体内均能抑制寨卡病毒。
Viruses. 2023 Mar 25;15(4):839. doi: 10.3390/v15040839.
6
Signaling events evoked by domain III of envelop glycoprotein of tick-borne encephalitis virus and West Nile virus in human brain microvascular endothelial cells.蜱传脑炎病毒和西尼罗河病毒包膜糖蛋白结构域 III 在人脑血管内皮细胞中引发的信号事件。
Sci Rep. 2022 May 25;12(1):8863. doi: 10.1038/s41598-022-13043-1.
7
Engineering the Single Domain Antibodies Targeting Receptor Binding Motifs Within the Domain III of West Nile Virus Envelope Glycoprotein.工程化靶向西尼罗河病毒包膜糖蛋白结构域III内受体结合基序的单域抗体
Front Microbiol. 2022 Apr 1;13:801466. doi: 10.3389/fmicb.2022.801466. eCollection 2022.
噬菌体展示肽筛选物对日本脑炎病毒感染的体外和体内抗病毒活性。
Antiviral Res. 2020 Feb;174:104673. doi: 10.1016/j.antiviral.2019.104673. Epub 2019 Dec 5.
4
West Nile virus vaccines - current situation and future directions.西尼罗河病毒疫苗——现状与未来方向。
Hum Vaccin Immunother. 2019;15(10):2337-2342. doi: 10.1080/21645515.2019.1621149. Epub 2019 Jul 10.
5
Antiviral peptides as promising therapeutic drugs.抗病毒肽作为有前途的治疗药物。
Cell Mol Life Sci. 2019 Sep;76(18):3525-3542. doi: 10.1007/s00018-019-03138-w. Epub 2019 May 17.
6
Drug repurposing for new, efficient, broad spectrum antivirals.药物重定位用于新型、高效、广谱抗病毒药物。
Virus Res. 2019 Apr 15;264:22-31. doi: 10.1016/j.virusres.2019.02.011. Epub 2019 Feb 19.
7
Cellular Targets for the Treatment of Flavivirus Infections.用于治疗黄病毒感染的细胞靶标。
Front Cell Infect Microbiol. 2018 Nov 12;8:398. doi: 10.3389/fcimb.2018.00398. eCollection 2018.
8
Innovation and trends in the development and approval of antiviral medicines: 1987-2017 and beyond.抗病毒药物的研发和审批的创新与趋势:1987-2017 年及以后。
Antiviral Res. 2018 Jul;155:76-88. doi: 10.1016/j.antiviral.2018.05.005. Epub 2018 May 15.
9
Phage-Displayed Peptides Selected to Bind Envelope Glycoprotein Show Antiviral Activity against Dengue Virus Serotype 2.筛选出的与包膜糖蛋白结合的噬菌体展示肽对登革热病毒2型具有抗病毒活性。
Adv Virol. 2017;2017:1827341. doi: 10.1155/2017/1827341. Epub 2017 Sep 10.
10
Osteopontin facilitates West Nile virus neuroinvasion via neutrophil "Trojan horse" transport.骨桥蛋白通过中性粒细胞“特洛伊木马”运输促进西尼罗河病毒神经侵袭。
Sci Rep. 2017 Jul 5;7(1):4722. doi: 10.1038/s41598-017-04839-7.